Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.144ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.288ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.439ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.408ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.256ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.7 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.460ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.262ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.5 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.30.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.122.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.256ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.248ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used